Biomaterials Market Size & Share, by Type of Materials - (Metallic, Ceramic, Polymer, Natural); Application - (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound healing, Neurological Disorders, Tissue Engineering, Ophthalmology) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 1375
Published Date: Feb 06, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Biomaterials Landscape

Covestro AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
HMA Group Holdings, LLC
Victrex plc
Corbion N.V.
Mitsubishi Chemical Group Holdings
AB Specialty Silicones, LLC
CeramTec GmbH
Olympus Corporation
Gelita AG
Evonik Industries AG

Browse Key Market Insights with Data Illustration:

Biomaterials Market Size, Share | Global Industry Report 2023-2033

In the News

Olympus Corporation declared the acquisition of FH ORTHO SAS, to build its portfolio on novel solutions to use in MIS procedures in ligament repair and foot, ankle, and trauma surgery.
FDA NEWS designated the Bonalive biomaterials’ bone graft substitute as Breakthrough Device. The orthopedic granules of the substitute are made of bioactive glass used to fill bony voids and gaps to protect against microbial colonization during the bone healing process.

Frequently Asked Questions (FAQ)

Rising disposable income and the growing prevalence of neurological disorders are the major factors driving the growth of the botulinum toxin market.

The market is anticipated to attain a CAGR of 10% over the forecast period, i.e., 2023-2033.

High cost of botulinum toxin methods and the rise of COVID-19 are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Merz Pharma GmbH & Co. KgaA, USWM LLC, Revance Therapeutics, Inc., Ipsen Group, Medytox, Inc., NestlÃ© S.A., HUGEL, Inc., AbbVie Inc., Galderma Group, and Evolus, Inc. and Object Pharma, Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, gender, age group, end-user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Biomaterials Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the market?

What would be the CAGR of market over the forecast period?

What are the challenges affecting the market growth?

Which region will provide more business opportunities for growth of market in future?

Who are the major players dominating the market?

How are the company profiles selected?

5) What are the segments in the botulinum toxin market?

6) Which segment captures the largest market size in end-user in the botulinum toxin market?